✦ LIBER ✦

Randomized phase II feasibility study of combining the matrix metalloproteinase inhibitor BMS-275291 with paclitaxel plus carboplatin in advanced non-small cell lung cancer

✍ Scribed by DOUILLARD, J

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomized, multicenter, phase II study

✍ Mazzanti, Paola; Massacesi, Cristian; Rocchi, Marco B.L.; Mattioli, Rodolfo; Lip 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 216 KB

Phase II study of concurrent thoracic ra

✍ Takayama, Koichi; Inoue, Koji; Tokunaga, Shoji; Matsumoto, Takemasa; Oshima, Tsu 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 247 KB

Phase II study of a one hour paclitaxel

✍ Evans, W.K; Earle, C.C; Stewart, D.J; Dahrouge, S; Tomiak, E; Goss, G; Logan, D; 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 147 KB

A phase II study of weekly paclitaxel co

✍ Inoue, Akira; Usui, Kazuhiro; Ishimoto, Osamu; Matsubara, Nobuyuki; Tanaka, Masa 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 100 KB

Phase I/II study of S-1 plus carboplatin

✍ Kenji Tamura; Isamu Okamoto; Tomohiro Ozaki; Tatsuhiko Kashii; Koji Takeda; Masa 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 149 KB

Randomised phase II study of ASA404 comb

✍ McKeage, M J; Von Pawel, J; Reck, M; Jameson, M B; Rosenthal, M A; Sullivan, R; 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 174 KB